Neogen Chemicals Ltd. · NSE:NEOGEN
Neogen Chemicals — Q2 FY27 Earnings Presentation
36 slides from Neogen Chemicals's earnings presentation, Nov 1, 2026
Slide 1: Exchange filing cover letter
November 1, 2026 BSE Limited National Stock Exchange of India Limited Department of Corporate Services Listing Department, Floor 25, Phiroze Jeejeebhoy Towers, Exchange Plaza, Dalal Street, Kala Ghoda, Fort Bandra Kurla Complex, Bandra (East), Mumbai - 400 001 Mumbai – 400 051 Scrip Code No: 542665
Slide 2: Q2 FY27 Earnings Presentation
Delivering Performance Sustaining Trust Creating Value Q2 FY27 Earnings Presentation November 2026
Slide 3: Safe Harbor
Safe Harbor Certain statements in this document may be forward-looking statements. Such forward looking statements are subject to certain risks and uncertainties like regulatory changes, local political or economic developments, and many other factors that could cause our actual results to differ ma
Slide 4: Table of Contents
Table of Contents 01 02 03 04 05 06 Q2 FY27 Introduction to Industry Overview: Way Sustainability & Contact Us Financial Neogen Chemicals Lithium-Ion Batteries Forward CSR Initiatives Performance & Expansion Initiatives 3
Slide 5: Q2 FY27 Financial Performance & Expansion Initiatives
Q2 FY27 Financial Performance & Expansion Initiatives 4
Slide 6: Performance Highlights – Q2 FY27
Performance Highlights – Q2 FY27 Q2 FY27 Revenue break-up** INR in crore Standalone Consolidated 66% 34% Revenues 39% | 288 42% | 296* Domestic *Exports *Including deemed exports Gross Profit 27% | 121 36% | 133 80% EBITDA 54% | 54 51% | 45 20% PAT 127% | 21 144% | 8 Organic Inorganic **Consolidated
Slide 7: Financial Summary – Q2 FY27
Financial Summary – Q2 FY27 REVENUE Standalone Consolidated ● Delivered robust growth, navigating Middle East geopolitical conflicts, supply chain INR in crore friction, and feedstock cost inflation 288 296 ● Led by sustained volume improvement in core segments, anchored by 207 209 Organolithium's e
Slide 8: Revenue break-up – Q2 & H1 FY27 (consolidated)
Revenue break-up – Q2 & H1 FY27 (consolidated) Organic Chemicals Inorganic Chemicals Battery Chemicals 238 37 58 184 24 5 Q2 FY26 Q2 FY27 Q2 FY26 Q2 FY27 Q2 FY26 Q2 FY27 114 56 432 349 46 11 H1 FY26 H1 FY27 H1 FY26 H1 FY27 H1 FY26 H1 FY27 7
Slide 9: Profit & Loss Statement (Standalone)
Financial Table – Profit & Loss Statement (Standalone) Particulars (INR In crore) Q2 FY27 Q2 FY26 Growth (%) H1 FY27 H1 FY26 Growth (%) Revenue 288.0 206.7 39% 540.3 391.3 38% Expenditure 234.3 171.7 36% 438.4 321.6 36% EBITDA 53.7 35.0 54% 101.9 69.6 46% EBITDA Margins 18.6% 16.9% +174 bps 18.9% 17
Slide 10: Profit & Loss Statement (Consolidated)
Financial Table – Profit & Loss Statement (Consolidated) Particulars (INR In crore) Q2 FY27 Q2 FY26 Growth (%) H1 FY27 H1 FY26 Growth (%) Revenue 296.0 208.7 42% 546.3 395.4 38% Expenditure 250.6 178.7 40% 452.7 333.9 36% EBITDA 45.3 30.0 51% 93.6 61.5 52% EBITDA Margins 15.3% 14.4% +95 bps 17.1% 15
Slide 11: Balance Sheet Snapshot (Consolidated)
Balance Sheet Snapshot (Consolidated) Particulars (INR In crore) Sep 30, 2026 Sep 30, 2025 Assets Non-Current Assets 2,004 983 Current Assets 2,001 1,319 • Standalone: Total Debt at INR 750 crore in H1 Total Assets 4,005 2,302 FY27; Net Debt at INR 378 crore • Consolidated: Total Debt at INR 1,560 c
Slide 12: Key Updates Q2 FY27
Expansion of Organolithium manufacturing facility • The board has approved expansion of Organolithium facility at Patancheru, Telangana from 300 MTPA to 600 MTPA with proposed estimated investment of upto INR 45 crore with additional revenue potential of INR 150 to INR 200 crore based on lithium pri
Slide 13: Update on various expansion initiatives
Update on various expansion initiatives Neogen Ionics’ Proposed Manufacturing Setup Manufacturing locations Land Area Year Planned Capacities Electrolyte Lithium Electrolyte Salts & Additives FY25 2,000 MT 400 MT Dahej SEZ 6,455 m2 FY26 - 1,100 MT FY27 - 1,000 MT Pakhajan, Dahej PCPIR (New site) 264
Slide 14: Update on Battery Chemicals (Neogen Ionics)
Update on Battery Chemicals (Neogen Ionics) Project Updates • Project mechanical completion timelines remain on schedule for Electrolytes (H1 FY27) and Electrolyte Salts (H2 FY27) • Electrolyte: Mechanical assembly is complete and trial runs have begun. Facility validation and product approvals by t
Slide 15: Management Commentary
Management Commentary Commenting on the performance, Dr. Harin Kanani, Managing Director, at Neogen Chemicals said: “We have delivered a robust all-round performance, demonstrating remarkable agility despite a challenging macroeconomic backdrop marked by geopolitical conflicts, supply chain friction
Slide 16: Historical Financial Trends (Consolidated)
Historical Financial Trends (Consolidated) Net Revenue from Operations* (INR crore) EBITDA (INR crore) Margin (%) 17.5% 15.9% 160 19.1% 16.3% 15.9% 136 137 25.0% 862 140 17.8% 110 1000 900 778 112 20.0% 686 691 120 800 700 487 100 87 15.0% 600 80 65 500 400 336 60 10.0% 300 40 5.0% 200 20 100 0 0 0.
Slide 17: Seasonal Variance Factors
Seasonal Variance Factors Neogen’s business has some Demand for Lithium-based Demand from the Consequently, investors are seasonal drivers, due to which the chemicals tends to be strong in agrochemicals segment is urged to compare financial Company tends to deliver Q4 as demand from the HVAC linked
Slide 18: Introduction to Neogen Chemicals
Introduction to Neogen Chemicals 17
Slide 19: Neogen Chemicals – At a Glance
Neogen Chemicals – At a Glance 7 Manufacturing ISO 9001:2015, ISO 313 Sites + 2 R&D 1,058* 14001:2015, ISO 20400:2017 & 816* 21%* Facilities* ISO 45001:2018 and others* Employees (of which Manufacturing units certified on Products developed by Net worth : March 5-year Revenue in-house R&D Infrastruc
Slide 20: Evolution of Neogen Chemicals
Evolution of Neogen Chemicals 1970’s to 1991 1991 to 2016 2016 to 2019 2020 to 2026 Pre-Neogen Site I Site I & II Multiple Sites • Mr. HT Kanani is a Chemical • ‘Neogen Chemicals’ commenced • Acquired Solaris ChemTech • Doubled Inorganic Chemicals capacity from Engineer from IIT Bombay. His business
Slide 21: Major Milestones
Major Milestones Leading manufacturer of Bromine and Lithium-based specialty chemicals since 1989 • Incorporation • Started • Achieved • Raised INR • Increased the • Increased • Signed • Approved • Expanded • Promoter as a private manufacturing turnover of 132 crore capacity of Organic licensing Mer
Slide 22: Business Overview
Business Overview Organic Chemicals Inorganic Chemicals Bromine Compounds Organolithium The portfolio includes specialty, inorganic lithium-based Organic compounds containing bromine, N Butyl Lithium and other organolithium chemical products which find applications across multiple chlorine, fluorine
Slide 23: Core Strategic Strengths
Core Strategic Strengths Strong Leadership Diversified Global Integrated Strong R&D Pioneered in Strategic Team with Deep Domain Customer Manufacturing & and Innovation Advanced Battery Partnerships Expertise in Specialty Base Scalable Infrastructure Capability Materials Chemistry Manufacturing • Ov
Slide 24: Experienced Leadership Team
Experienced Leadership Team Dr. Harin Kanani Mr. Anurag Surana, Mr. Sanjay Mehta Dr. Haridas Kanani, Managing Director Non-Executive Non-Executive Chairman Emeritus Neogen Chemicals Limited Chairman, NCL Chairman, NIL (NCL & NIL) • Holds a bachelor’s degree in • Holds a bachelor’s degree in commerce
Slide 25: Strong Manufacturing Infrastructure – Neogen Chemicals
Strong Manufacturing Infrastructure – Neogen Chemicals Factory Land Area Land Utilisation Capacity Certifications of Manufacturing Facilities Lithium Electrolyte Electrolyte Salts & Additives ISO 9001:2015, ISO 26000:2010, ISO 31000:2018, ISO 37001:2016 from Mahape (Since 1991) 4,045 m2 100% 69 m3 9
Slide 26: Driving Innovation Through R&D
Driving Innovation Through R&D Established two R&D units 1 2 PRODUCTS 133-member dedicated R&D team, including 11 Ph. D. 20 313 Portfolio growth surge from 2001 to Q2 FY27 4 3 Focus on R&D to drive sustained growth; to continue to deploy resources MD actively involved and spend significant time over
Slide 27: Neogen's Global Footprint
Neogen’s Global Footprint Japan Subsidiary: • Neogen Chemicals Japan Corporation Limited China • Serves as Neogen’s key arm to deepen Europe Korea strategic ties with Japanese companies. Representative Offices: • Germany USA Japan • Korea Export sales of in Q2 FY27 34% Middle East 26
Slide 28: Industry Tailwinds: Neogen's Strategic Positioning
Industry Tailwinds : Neogen’s Strategic Positioning Growth Driver Opportunity for Neogen Positioned as a preferred alternative manufacturing partner for global customers across specialty chemicals, pharma Redefining Global Supply Chains intermediates, agrochemicals, and battery materials. Capturing
Slide 29: Industry Overview: Lithium-ion Batteries
Industry Overview Lithium-ion Batteries 28
Slide 30: Strong Opportunities in Lithium Battery Sector – India
Strong Opportunities in Lithium Battery Sector – India Government’s PLI Scheme for ACC Direct investment of around INR Rebidding: Govt. has invited global Proposed PLI for battery Batteries: Backed by an outlay of 45,000 crore in ACC Battery storage bids to establish 10 GWh of giga-scale components
Slide 31: Strong Opportunities in Lithium Battery Sector – Global
Strong Opportunities in Lithium Battery Sector – Global Demand Estimates for the Global Market (By 2030) Estimated Battery requirement (GWh) Estimated Electrolyte demand (KT) Estimated Lithium Salt demand (KT) 3,500 3,500 400 350 3,000 3,000 300 141 1,125 2,500 2,500 2,000 1,500 2,000 250 366 200 1,
Slide 32: Way Forward
Way Forward Leverage strong R&D expertise to Deep inroads in introduce the Battery Expand capabilities innovative Materials segment in adjacent high- offerings end complex Enhance focus on chemistries CSM & Advanced Intermediates Augment the through portfolio capacities of expansion Organic and Inor
Slide 33: Driving Sustainable Growth Through ESG Excellence
Driving Sustainable Growth Through ESG Excellence Clean Energy Robust Ethical Strengthening Focus Oversight Foundation Corporate Governance Dedicated CAPEX via ESG risks are formally Comprehensive Aligned with best wholly owned integrated into the policies covering all 9 governance practices, subsid
Slide 34: CSR Approach: Focusing On The Greater Good
CSR Approach: Focusing On The Greater Good Shaping an Inclusive and Sustainable Future CSR Focus Areas (FY26) INR 14.97 Lakh INR 11.26 Lakh INR 56.01 Lakh INR 34.10 Lakh INR 20.95 Lakh Environment Healthcare Education Water Conservation & Natural Rural Development and Resource Management Women Empow
Slide 35: Contact Us
Contact Us About Neogen Chemicals Limited Incorporated in 1989, Neogen Chemicals Ltd. (NSE Code: NEOGEN; BSE Code: 542665) is India’s one of the largest, oldest and most diverse manufacturers of Bromine-based and Lithium-based specialty chemicals. Products Its specialty chemicals product offerings c
Slide 36: Thank You
dss NEOGEN® HEMICALS LTD. iS